NPI registry status
Active
2026 NPPES data Optometrist NPI 1063574176 O.D.
Verify on CMS → Mark Novotny, O.D.
Optometrist in Gainesville, Georgia.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 61,426 in Optometrist, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
406
Medicare Part D claims · 174 beneficiaries · Optometrist avg: 279
Generic prescribing
43%
generic claims · 57% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
90.6/100
▲ 7 pts above national avg 83.5 · Exceptional
Industry payments
$53.54
3 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Mark Novotny, O.D. reported a CMS MIPS final score of 90.6/100 - above the 83.5 national average - and filed 406 Medicare Part D claims in 2024.
- 90.6/100
- MIPS score · +7 vs avg
- 406
- Part D claims, 2024
- 43%
- generic prescribing
- $53.54
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Mark Novotny, O.D.
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1063574176), first enumerated 12/14/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 406 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 90.6/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$53.54 in reported industry payments (3 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1063574176 · Optometrist
NPI-10 · ENUM-LEGACY · TAX-MEGA · MIPS-ABOVE · RX-LIGHT · BOOK-LIGHT · PHOTO-FINISH
- NPI-10 1063574176
- ENUM-LEGACY 2006
- TAX-MEGA 61K Optometrist
- MIPS-ABOVE 90.6/100
- RX-LIGHT 406
- BOOK-LIGHT 1,410 in Georgia
- PHOTO-FINISH Hadia Choudhary, O.D. · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Novotny · this p…
Novotny · this provider
90.6 MIPS pts
- Hadia Choudhary,…
Hadia Choudhary, O.D.
90.6 MIPS pts
- Sheila Brandow, …
Sheila Brandow, OD
90.7 MIPS pts
- Troy Currier, OD…
Troy Currier, OD
90.7 MIPS pts
- Andrew Piester, …
Andrew Piester, O.D.
90.7 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Mark Novotny, O.D.'s MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
91 ≥ 58th percentile 58% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Mark Novotny, O.D. sits
This provider among optometrist peers
Across the 6,187 optometrist providers who report both Medicare Part D prescribing and a MIPS quality score, Mark Novotny, O.D. writes more Part D claims than 55% of them and scores higher on MIPS quality than 62% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one optometrist peer from a representative sample of 60; the gold marker is Mark Novotny, O.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
What does the federal data show about Mark Novotny, O.D.?
High performer (top quartile)Primary specialty
Optometrist
Medicare Part D claims
406 46% vs specialty avg
MIPS final score
90.6/100 7.1 pts vs avg
Specialty distribution in Georgia
How Optometrist compares to other specialties among Georgia providers
Medicare quality performance, MIPS
Mark Novotny, O.D.'s 2023 MIPS final score plotted against the Optometrist national average
- MIPS Final Score
- 90.6/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1063574176 |
|---|---|
| Specialty | Optometrist |
| Credentials | O.D. |
| Gender | Male |
| NPI Issued | 12/14/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
90.646
Final Score
Measured-score avg: 83.5
100
Quality
68.82
Cost
Reporting: Group practice
Hospital and facility affiliations
Facilities where Mark Novotny, O.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Gainesville Eye Associates LLC
Gainesville, GA
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Mark Novotny, O.D.. Source: openpaymentsdata.cms.gov.
Total received
$54
Largest payer
Dompe US, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Brand-heavy
Mark Novotny, O.D. - brand share 57.0%
Optometrist average
57% brand-name claims vs 43% generic, on 406 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
406
Total Claims
$150K
Total Drug Cost
174
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 721.8
- Total Day Supply
- 19,861
- Brand vs Generic
- 57% brand / 43% generic
- Brand Drug Cost
- $143K
- Generic Drug Cost
- $7K
- Antibiotic Claims
- 26
Patient Demographics
- Average Patient Age
- 75.5 years
- Avg HCC Risk Score
- 1.49
- Gender Split
- 70% female / 30% male
- Age Distribution
- <65: 13, 65-74: 69, 75-84: 66, 85+: 26
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Mark Novotny, O.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Restasis
Restasis
78 claims
- Cyclosporine
Cyclosporine
52 claims
- Latanoprost
Latanoprost
50 claims
- Tobramycin-Dexamet… 28
Tobramycin-Dexamethasone
28 claims
- Dorzolamide-Timolol 26
Dorzolamide-Timolol
26 claims
- Cephalexin 21
Cephalexin
21 claims
- Brimonidine Tartrate 18
Brimonidine Tartrate
18 claims
- Loteprednol Etabon… 16
Loteprednol Etabonate
16 claims
| Drug | Claims |
|---|---|
| Restasis Cyclosporine | 78 |
| Cyclosporine | 52 |
| Latanoprost | 50 |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 28 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 26 |
| Cephalexin | 21 |
| Brimonidine Tartrate | 18 |
| Loteprednol Etabonate | 16 |
| Lumigan Bimatoprost | 14 |
| Prednisolone Acetate | 12 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Optometrist Overview
How Mark Novotny, O.D. fits within the Optometrist landscape nationally.
61,426
Optometrist Providers in US
56
States with Optometrist
279
Avg Claims per Provider
Mark Novotny, O.D.'s 406 claims are above the specialty average of 279.
Nationwide Optometrist peers with similar MIPS or enrollment year
Two federal-record peer sets for Novotny, both outside Georgia so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (90.6 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Optometrist Providers in Georgia
Other clinicians with the same primary specialty enrolled in Georgia, drawn from the same CMS NPPES roster as Novotny.
One of 1,410 Optometrist providers enrolled in Georgia, 5 are shown here.
Dr. Sara Aamir
O.D.
Canton, GA
Dr. Geoffrey Abraham
O.D.
Lawrenceville, GA
Dr. Justin Abraham
OD
Atlanta, GA
Dr. Nhora Abril
OD
Roswell, GA
Dr. Sampson Abu
OD
Atlanta, GA
Compare Optometrist nationally: see state-by-state distribution →
Frequently Asked Questions
What is Mark Novotny, O.D.'s specialty? ▼
Mark Novotny, O.D. specializes in Optometrist and practices in Gainesville, Georgia. Credentials: O.D..
How much does Mark Novotny, O.D. prescribe under Medicare Part D? ▼
In 2024, Mark Novotny, O.D. wrote 406 Medicare Part D claims totaling $150K in drug costs for 174 beneficiaries.
What is Mark Novotny, O.D.'s Medicare quality score? ▼
Mark Novotny, O.D. has a CMS MIPS Final Score of 90.6/100 (Quality: 100, Cost: 68.8). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Mark Novotny, O.D. located? ▼
Mark Novotny, O.D. is located at 535 JESSE JEWELL PKWY SE, Gainesville, GA, 30501. Phone: (770) 534-1711.
What is Mark Novotny, O.D.'s NPI number? ▼
Mark Novotny, O.D.'s National Provider Identifier (NPI) is 1063574176, issued on 12/14/2006.
Does Mark Novotny, O.D. prescribe more brand-name or generic drugs? ▼
Mark Novotny, O.D.'s prescribing is 57% brand-name and 43% generic drugs by claim count, with $143K in brand drug costs.
How many Optometrist providers are there in the US? ▼
There are 61,426 Optometrist providers across 56 states in the US. The average Optometrist provider writes 279 Medicare Part D claims per year.
What drugs does Mark Novotny, O.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Mark Novotny, O.D.'s most frequently prescribed drugs include Restasis, Cyclosporine, Latanoprost. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Mark Novotny, O.D. accept Medicare? ▼
Mark Novotny, O.D. appears in CMS Medicare data with 406 Part D claims and 174 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Mark Novotny, O.D.'s credentials? ▼
Mark Novotny, O.D.'s NPI is 1063574176 with credentials O.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.